The current status of analgesic brain stimulation

Area of Science:

• Neurosurgery
• Pain Management
• Neuroscience

Background:

• Chronic pain, including peripheral and deafferentation pain, presents significant management challenges.
• Brain stimulation is an emerging therapeutic modality for intractable pain.
• Understanding the neurobiological mechanisms of pain and analgesia is crucial for developing effective treatments.

Purpose of the Study:

• To review nine years of clinical experience with analgesic brain stimulation techniques.
• To evaluate the efficacy of periaqueductal gray (PAG) stimulation for peripheral pain.
• To assess the effectiveness of subcortical somatosensory stimulation for deafferentation pain.

Main Methods:

• Retrospective review of patient data from nine years of clinical practice.
• Analysis of outcomes for patients treated with periaqueductal gray (PAG) stimulation.
• Analysis of outcomes for patients treated with subcortical somatosensory electrical stimulation.

Main Results:

• PAG stimulation achieved successful pain control in 16 out of 22 patients with peripheral pain.
• Subcortical somatosensory stimulation provided long-term dysesthesia control in 16 out of 40 patients with deafferentation pain.
• Tolerance to analgesic effects was observed, linked to serotonin turnover, and reversed by L-tryptophan supplementation.

Conclusions:

• Analgesic brain stimulation, particularly PAG and subcortical somatosensory stimulation, demonstrates significant efficacy in managing distinct types of chronic pain.
• The mechanism of analgesia via PAG stimulation involves beta-endorphin release and activation of descending pain-inhibitory pathways.
• Tolerance to stimulation can be mitigated by modulating neurotransmitter precursors, such as using L-tryptophan to reverse decreased serotonin turnover.